CD molecules (ligands)

FR104 (anti-CD28) is an antibody targeting CD28.

Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica

Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica

Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica

Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica

Ocaratuzumab (anti-CD20) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab (anti-CD20) exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).Purity&gt95%

Ocaratuzumab (anti-CD20) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab (anti-CD20) exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).Purity&gt95%

Ocaratuzumab (anti-CD20) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab (anti-CD20) exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).Purity&gt95%

Ocaratuzumab (anti-CD20) is an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, with a Kd of ~100 pM. Ocaratuzumab (anti-CD20) exhibits more effective antibody-dependent cell-mediated cytotoxicity (ADCC).Purity&gt95%

Purity:&gt90%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description：Receptors that recognize the Fc portion of IgG are divided into three groups designated Fc gamma RI, RII, and RIII, also known respectively as CD64, CD32, and CD16. Fc

Purity:&gt90%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description：Receptors that recognize the Fc portion of IgG are divided into three groups designated Fc gamma RI, RII, and RIII, also known respectively as CD64, CD32, and CD16. Fc

Purity:&gt90%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description：Receptors that recognize the Fc portion of IgG are divided into three groups designated Fc gamma RI, RII, and RIII, also known respectively as CD64, CD32, and CD16. Fc